Belgium Unveils New Leniency Guidelines
Client Alert | 1 min read | 10.24.07
CompetitionLaw360
Belgium has revealed a new set of guidelines for its leniency program, hoping to better employ the competition tool that has enabled U.S., EU and Asian antitrust authorities to unravel some of the world’s most notorious cartels. Belgium published a revamped version of its 2004 leniency initiative in the Belgium State Gazette, indicating a desire to keep up with the strides and various refinements that have been made to such programs over the years.
Under the new legislation, Belgium will reportedly accept oral leniency and implement a marker system, an increasingly popular feature among immunity programs. The acceptance of oral or other nonwritten statements from cartel members applying for leniency will help to protect companies concerned about producing hard documents that could later be subpoenaed or discoverable in civil litigation elsewhere, especially in the U.S. The marker system would enable cartel members to come forward and reserve places in line for leniency even before they have gathered information. This, regulators believe, will help them to capitalize on cartel members’ distrustful paranoia and ensure that members would come forward quickly.
Though the council has received an estimated 20 immunity applications since the program was first introduced in 2004, most of those were the result of companies applying for leniency in several jurisdictions, also known as double-dips. Seeking to toughen up the program, the council began the process of revising its leniency program back in September, inviting practitioners to comment on the process for the first time ever.
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development
